Literature DB >> 8613471

Interferon-gamma induced cell death in a cultured human salivary gland cell line.

A J Wu1, Z J Chen, M Tsokos, B C O'Connell, I S Ambudkar, B J Baum.   

Abstract

Increased levels of several cytokines, including interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha), have been demonstrated in the salivary gland microenvironment of patients with Sjögren's syndrome (SS). How these cytokines may be contributing to the pathogenesis of the disease is not well understood. This study examined the role of IFN-gamma +/- TNF-alpha on cellular death in a cultured human salivary gland cell line (HSG). Cells treated long-term with IFN-gamma +/- TNF-alpha demonstrate a profound antiproliferative effect with a decrease in cell number to below that initially plated. Treatment of HSG cells with TNF-alpha alone did not have any significant effects on growth but did increase the expression of the IFN-gamma receptor. Cells labelled with propidium iodide and anti-digoxigenin dUTP/dATP were examined by flow cytometry to determine the percentage of cells exhibiting low DNA content and DNA strand breaks. The percentage of cells exhibiting subdiploid DNA and DNA strand breaks increased with increased time of exposure to the cytokines. The maximum percentage of cells exhibiting DNA degradation at 12 days was 58% for cells treated with IFN-gamma + TNF-alpha, 31% for IFN-gamma treated cells, and < 5% for TNF-alpha-treated and untreated cells. The cells with subdiploid ( < 2n) DNA were subsequently demonstrated to represent two populations, both with evidence of increased DNA strand breaks but with differing light scatter characteristics. One population had features of cells undergoing necrosis, whereas the second population exhibited features of apoptosis. These findings were confirmed by transmission electron microscopy. Cells not exposed to cytokines did not exhibit significant evidence of either death process. We conclude that long-term exposure of a human salivary gland epithelial cell line to IFN-gamma +/- TNF-alpha leads to increased DNA degradation and subsequent cell death. This suggests a potential SS disease mechanism and implicates the role of the epithelial cell in this disease as an important area for future study.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613471     DOI: 10.1002/(SICI)1097-4652(199605)167:2<297::AID-JCP14>3.0.CO;2-5

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

Review 1.  Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

Authors:  B M Lodde; B J Baum; P P Tak; G Illei
Journal:  Ann Rheum Dis       Date:  2006-07-31       Impact factor: 19.103

2.  Whole blueberry powder modulates the growth and metastasis of MDA-MB-231 triple negative breast tumors in nude mice.

Authors:  Lynn S Adams; Noriko Kanaya; Sheryl Phung; Zheng Liu; Shiuan Chen
Journal:  J Nutr       Date:  2011-08-31       Impact factor: 4.798

3.  Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases.

Authors:  John C Hall; Livia Casciola-Rosen; Alan E Berger; Efstathia K Kapsogeorgou; Chris Cheadle; Athanasios G Tzioufas; Alan N Baer; Antony Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

4.  TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice.

Authors:  J L Vosters; N Roescher; G G Illei; J A Chiorini; P P Tak
Journal:  Oral Dis       Date:  2011-12-29       Impact factor: 3.511

Review 5.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

6.  Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjögren's syndrome.

Authors:  A B Peck; C Q Nguyen
Journal:  Scand J Immunol       Date:  2012-09       Impact factor: 3.487

7.  Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome.

Authors:  C P Robinson; S Yamachika; C E Alford; C Cooper; E L Pichardo; N Shah; A B Peck; M G Humphreys-Beher
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

8.  A role for matrix metalloproteinase 9 in IFNγ-mediated injury in developing lungs: relevance to bronchopulmonary dysplasia.

Authors:  Anantha Harijith; Rayman Choo-Wing; Sule Cataltepe; Ryuji Yasumatsu; Zubair H Aghai; Joakim Janér; Sture Andersson; Robert J Homer; Vineet Bhandari
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-07       Impact factor: 6.914

9.  Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome.

Authors:  C P Robinson; J Brayer; S Yamachika; T R Esch; A B Peck; C A Stewart; E Peen; R Jonsson; M G Humphreys-Beher
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.

Authors:  Hongen Yin; Peter Kosa; Xibao Liu; William D Swaim; Zhennan Lai; Javier Cabrera-Perez; Giovanni Di Pasquale; Indu S Ambudkar; Thomas H Bugge; John A Chiorini
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.